Optitropin’s Proviron (25 mg) tablets were submitted for independent testing to verify their potency. The sample, submitted by B Ware, an individual consumer with no commercial ties, was analyzed by Janoshik Analytical. The results confirmed that the sample contained 24.52 mg and 24.75 mg of Mesterolone per tablet in separate tests, representing 98.08% and 99% of the labeled claim of 25 mg.
The Average Measured Dosage was calculated at 24.63 mg, indicating a 98.54% potency of the labeled claim. Additionally, the Relative Standard Deviation (RSD%) was determined to be 0.66%, signifying high consistency between tested tablets. Since the RSD% is well below the 6% compliance threshold, the product meets pharmaceutical standards for uniformity.
Testing was initiated on 5 January 2024, with the sample received on 11 January 2024, and analysis conducted on the same day. The measured concentrations are within an acceptable pharmaceutical variance, confirming a high level of quality control for this batch.
This report is published to promote transparency and harm reduction, helping consumers make informed decisions regarding pharmaceutical product use.
Detailed Report
Product Overview
- Manufacturer: Optitropin
- Product Name: Proviron
- Active Ingredient: Mesterolone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral Tablet
Sample Acquisition and Testing
- Task Number: #37375
- Testing Ordered: 5 January 2024
- Sample Received: 11 January 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: B Ware (Individual)
- Analysis Paid For By: B Ware (Individual)
Testing Results
| Specification | Measured Concentration | Accuracy | Variance | RSD% | Compliance (RSD%) |
|---|---|---|---|---|---|
| 25 mg (as per label) | 24.52 mg | 98.08% | -1.92% | 0.66% | ✅ Compliant (≤6%) |
| 25 mg (as per label) | 24.75 mg | 99% | -1% |
- Average Measured Dosage: 24.63 mg
- Relative Standard Deviation (RSD %): 0.66%
- Compliance with RSD%: ✅ Compliant (≤6%)
Verification Details
- Verification URL: https://janoshik.com/tests/37375_8NPN8LT8PIZ3
Evaluation of Consumer-SubmEvaluation of Consumer-Submitted Testing
The analysis confirms that the Proviron (25 mg per tablet) sample meets its labeled claim, with measured concentrations of 98.08% and 99% accuracy. The Relative Standard Deviation (RSD%) of 0.66% indicates minimal dosage variability, confirming excellent uniformity between tested tablets.
Since the RSD% is significantly below the 6% compliance threshold, these results suggest strong manufacturing consistency within this batch. Such low RSD values reflect high-quality production processes and ingredient distribution.
As the sample was submitted by an independent consumer (B Ware) with no known commercial ties, there is no potential bias from reseller or manufacturer submissions. However, as with any single-batch test, additional independent testing across multiple batches is advised to validate product consistency over time.
Conclusion
The results confirm that Optitropin’s Proviron (25 mg) meets its labeled potency, with measured concentrations of 24.52 mg and 24.75 mg per tablet. The Average Measured Dosage of 24.63 mg represents 98.54% accuracy of the labeled claim, while the Relative Standard Deviation (RSD%) of 0.66% indicates exceptional uniformity between tablets.
This minor variation is well within standard pharmaceutical tolerances, suggesting high-quality control for this batch.
Consumers are encouraged to continue verifying product quality through independent third-party testing, as this remains a crucial step in harm reduction and informed decision-making.
Disclaimer
This report is for educational and harm reduction purposes only. The results pertain solely to the batch tested and may not reflect the quality of other batches. Although B Ware has no commercial interests, readers are encouraged to critically assess this information alongside third-party or independent data to form a comprehensive understanding of product consistency. Always consult healthcare professionals and adhere to local regulations before using such products.
